Tian Medicine shares raised 550 million of the purchase of raw materials in today's intraday plunge 9%

NetEase Finance January 19 Day medicine shares yesterday evening issued a notice said that the number of shares to be issued not more than 66.5 million shares (including the number), the issue of 8.27 yuan/shares, the total amount of fund-raising not more than 550 million yuan. The announcement indicated that the day medicine shares this issue is to include the holding shareholder pharmaceutical group and so on no more than 10 specific investors, all the issuers in cash to subscribe to this private issue of shares.　　Among them, the controlling shareholder Tianjin Pharmaceutical Group Co., Ltd. intends to subscribe for this non-public offering in cash, with a subscription rate of 46.8% per cent of this private offering.　　The Non-public offering raises funds to invest in the following three projects: the acquisition of Tianjin Tian ' an Pharmaceutical Co., Ltd. amino acid raw materials business and related assets and liabilities; acquisition of Tianjin Jin Yao Biotechnology Co., Ltd. Sewage Treatment environmental Protection project assets; technical upgrading and expansion of corticosteroid drugs. Tian Medicine shares said, the release is completed, the company will add amino acid raw drug business.　　The company's controlling shareholder's raw material drug assets have realized the whole listing, is advantageous to the company to integrate the raw drug business, reduces the cost through the synergy effect, and has used the company long time the management experience as well as the operation, the sale, the brand and so on the raw material medicine business competitiveness and the profitability.　　The shares of the stock today, the share price sharply lower open 5.93%, the largest decline of nearly 9%, trading active. Related News day drug shares proposed increase 550 million acquisition of raw material drug assets